NEW YORK and SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/ -- Forest
Laboratories, Inc. (NYSE: FRX), and Cypress Bioscience, Inc. (Nasdaq: CYPB)
will host a webcast to discuss milnacipran clinical data being presented at
the American College of Rheumatology annual conference. The webcast, which
will include a slide presentation, will occur on November 8, 2007 at
10:00am EST. Representing Forest Laboratories will be Dr. Lawrence Olanoff,
President and Chief Operating Officer of Forest and representing Cypress
Bioscience will be Dr. Jay Kranzler, Chairman and Chief Executive Officer
of Cypress. Also presenting on the webcast will be Dr. Daniel J. Clauw and
Dr. Philip Mease, two milnacipran study investigators that will provide an
overview of fibromyalgia syndrome and the current challenges faced by both
patients and physicians in managing this complex disease, as well as
discuss the milnacipran data findings being presented at ACR.
(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )
The webcast can be accessed at the URL: http://phx.corporate-
ir.net/phoenix.zhtml?p=irol-eventDetails&c=83198&eventID=1686016 (Due to
the length of the link, please copy and paste into you're browser.)
The webcast will also be available on the Forest Laboratories and
Cypress Bioscience websites at http://www.frx.com and http://www.cypressbio.com.
A replay of the conference call will be available until December 8,
2007 on both websites.
About Milnacipran:
Milnacipran is a unique dual-reuptake inhibitor, which preferentially
blocks the reuptake of norepinephrine with higher potency than serotonin,
two neurotransmitters known to play an essential role in regulating pain
and mood. It has been approved for the treatment of depression in over 32
countries and has been used by more than 5 million patients during more
than 10 years of commercial availability outside the U.S. Milnacipran is
being developed for fibromyalgia in the United States market jointly by
Forest and its licensor, Cypress Bioscience, Inc.
SOURCE Forest Laboratories, Inc. and Cypress Bioscience, Inc.
 back to top
Related links:
http://www.frx.com
http://www.cypressbio.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Charles Triano, Vice President- Investor
Relations of Forest Laboratories, Inc., +1-212-224-6714,
charles.triano@frx.com; or Sabrina Martucci Johnson, CFO, CBO,
Ex. VP, or Mary Gieson, Investor Relations,
Mgieson@cypressbio.com, both of Cypress Bioscience, Inc.,
+1-858-452-2323
|
